A New Era of Customer-Centricity with IFF Pharma Solutions' AnswerCenter Platform

December 13, 2024 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

Web-based customer platform provides answers at customers' fingertips

NEW YORK, Dec. 12, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions announces the launch of its new customer experience platform, AnswerCenter. This customized environment is designed to provide comprehensive support and an elevated user experience, underscoring IFF's commitment to customer-centricity and digital innovation. While personal customer relationships and connection points are imperative, the platform is another important offering, allowing customers to be in the driver's seat when they want to quickly access information. 

"Delivering the right product at the right time, every time, is always our priority," said Rina Chokshi, global commercial marketing director, IFF Pharma Solutions. "With IFF's AnswerCenter, we can offer a more efficient, personalized digital experience that brings customers closer to our solutions and expertise. Thanks to this new, comprehensive catalog of products and essential excipient information, along with advanced filtering options, exploring IFF's excipient innovations and content has never been easier."

AnswerCenter provides an opportunity for customers to transform the way they approach pharmaceutical challenges. Featuring an intuitive and user-friendly interface, it allows customers to effortlessly browse products by market, technology, or segment, filter by key attributes, and swiftly request samples or quotes. This state-of-the-art platform offers detailed technical information, regulatory guidelines, and updates, streamlining the process of finding tailored solutions. Personalized content ensures each visit is unique, empowering users to find exactly what they're looking for.

Customers can explore excipients and ingredients across various industry segments including pharmaceuticals, biologics and biomedical, dietary supplements, industrial solutions, and food. With access to a plethora of documents related to product brands, quality, technical data sheets, supply chain and regulatory support, AnswerCenter serves as a central hub for addressing complex pharmaceutical challenges and enhancing customer engagement.

AnswerCenter is a key component of IFF's ongoing investments in digitalization and in enhancing the overall customer experience. Visit the new platform at http://answercenter.iff.com.

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook

©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contact:
Reena Chaudhary
Global Communications Manager
+91 9769820494
[email protected] 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.